Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Schwartz

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Neuromuscular Diseases|April 18, 2022
Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?Oliver Schwartz, Heike Kölbel, Astrid Blaschek, et al.
Orphanet Journal of Rare Diseases|July 19, 2022
Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyAndreas Hahn, René Günther, Albert Ludolph, et al.
Orphanet Journal of Rare Diseases|October 26, 2022
Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyAndreas Hahn, René Günther, Albert Ludolph, et al.
Journal of Neuromuscular Diseases|July 18, 2022
Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?Astrid Blaschek, Heike Kölbel, Oliver Schwartz, et al.
Molecular Genetics and Metabolism Reports|December 14, 2020
L-Fucose treatment of FUT8-CDGJulien H Park, Janine Reunert, Miao He, et al.
Der Nervenarzt|October 15, 2021
[Newborn screening program for spinal muscular atrophy]Heike Kölbel, Katharina Vill, Oliver Schwartz, et al.
Journal of Neuromuscular Diseases|April 26, 2018
Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in GermanyAstrid Pechmann, Thorsten Langer, David Schorling, et al.
Journal of Neurology|October 7, 2020
Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term dataAnna Rada, Robert Birnbacher, Claudio Gobbi, et al.
Brain : a Journal of Neurology|July 24, 2019
SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosisJulien H Park, Christiane Elpers, Janine Reunert, et al.
Journal of Neuromuscular Diseases|March 8, 2020
Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?Wolfgang Müller-Felber, Katharina Vill, Oliver Schwartz, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Neuromuscular Diseases|April 18, 2022
Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?Oliver Schwartz, Heike Kölbel, Astrid Blaschek, et al.
Orphanet Journal of Rare Diseases|July 19, 2022
Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyAndreas Hahn, René Günther, Albert Ludolph, et al.
Orphanet Journal of Rare Diseases|October 26, 2022
Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyAndreas Hahn, René Günther, Albert Ludolph, et al.
Journal of Neuromuscular Diseases|July 18, 2022
Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?Astrid Blaschek, Heike Kölbel, Oliver Schwartz, et al.
Molecular Genetics and Metabolism Reports|December 14, 2020
L-Fucose treatment of FUT8-CDGJulien H Park, Janine Reunert, Miao He, et al.
Der Nervenarzt|October 15, 2021
[Newborn screening program for spinal muscular atrophy]Heike Kölbel, Katharina Vill, Oliver Schwartz, et al.
Journal of Neuromuscular Diseases|April 26, 2018
Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in GermanyAstrid Pechmann, Thorsten Langer, David Schorling, et al.
Journal of Neurology|October 7, 2020
Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term dataAnna Rada, Robert Birnbacher, Claudio Gobbi, et al.
Brain : a Journal of Neurology|July 24, 2019
SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosisJulien H Park, Christiane Elpers, Janine Reunert, et al.
Journal of Neuromuscular Diseases|March 8, 2020
Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?Wolfgang Müller-Felber, Katharina Vill, Oliver Schwartz, et al.
Pageof 4